Status:
COMPLETED
Samsung Medical Center-Lymphoma Cohort Study-II
Lead Sponsor:
Samsung Medical Center
Conditions:
Lymphoma
Eligibility:
All Genders
19+ years
Brief Summary
The purpose of this study is to establish a model which can predict the treatment outcome and the risk of treatment-related morbidity in patients with lymphoma.
Detailed Description
Although the cure rate of lymphoma has been increased due to the development of newer effective drugs, a substantial portion of patients is still suffered from relapse. Furthermore, the treatment-rela...
Eligibility Criteria
Inclusion
- Patients who were diagnosed as lymphoma
- Over 19 years old
- Patients who agreed the enrollment of study
- Informed consent for sampling
Exclusion
- •Patients who do not want to join the study
Key Trial Info
Start Date :
February 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 28 2017
Estimated Enrollment :
1358 Patients enrolled
Trial Details
Trial ID
NCT01877109
Start Date
February 1 2012
End Date
February 28 2017
Last Update
October 27 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea